Disease Control Priorities, Third Edition (Volume 6)

Disease Control Priorities, Third Edition (Volume 6)
Author: King K. Holmes
Publisher: World Bank Publications
Total Pages: 1027
Release: 2017-11-06
Genre: Medical
ISBN: 1464805253

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.

Management of MDR-TB

Management of MDR-TB
Author: World Health Organization
Publisher: World Health Organization
Total Pages: 61
Release: 2009
Genre: Medical
ISBN: 9241547766

Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) are increasingly encountered in resource-limited settings. In the context of a national response to MDR- and XDR-TB, health workers in TB clinics (in district hospitals and some accredited health centers) will need to diagnose MDR-TB, initiate second-line anti-TB drugs, and monitor MDR-TB treatment. This Field Guide was created to help health workers carry out these tasks. It is a job aid that medical officers and TB nurses are meant to use frequently during the day for quick reference. It is based on the Emergency Update 2008 of Guidelines for Programmatic Management of Drug-resistant Tuberculosis, and may be considered a companion document to these guidelines. It also draws on the experience of the international health NGO Partners In Health (PIH) in many countries. This module should be introduced to health workers in the context of a training course with a strong emphasis on TB-HIV co-management.

Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis

Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis
Author: World Health Organization
Publisher:
Total Pages: 0
Release: 2015-04-20
Genre: Medical
ISBN: 9789241501583

This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response to the Sixty-second World Health Assembly's resolution on prevention and control of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Resolution WHA62.15, adopted in 2009, calls on Member States to develop a comprehensive framework for the management and care of patients with drug-resistant TB. The recommendations contained in these guidelines address the most topical questions concerning the programmatic management of drug-resistant TB: case-finding, multidrug resistance, treatment regimens, monitoring the response to treatment, and selecting models of care. The guidelines primarily target staff and medical practitioners working in TB treatment and control, and partners and organizations providing technical and financial support for care of drug-resistant TB in settings where resources are limited.

Guidelines for the Programmatic Management of Drug-resistant Tuberculosis

Guidelines for the Programmatic Management of Drug-resistant Tuberculosis
Author: World Health Organization
Publisher: World Health Organization
Total Pages: 271
Release: 2008
Genre: Business & Economics
ISBN: 9241547588

The emergence of extensively drug-resistant strains of tuberculosis, especially in countries with a high prevalence of human immunodeficiency virus, is a serious threat to global public health and jeopardizes efforts to effectively control the disease. This publication offers updated recommendations for the diagnosis and management of drug-resistant tuberculosis in a variety of geographical, economic and social settings, and the recording of data that enables the monitoring and evaluation of programs.--Publisher's description.

Adult-Gerontology Practice Guidelines

Adult-Gerontology Practice Guidelines
Author: Jill C. Cash, MSN, APN, FNP-BC
Publisher: Springer Publishing Company
Total Pages: 1109
Release: 2023-02-13
Genre: Medical
ISBN: 0826166040

Praise for the First Edition: "Because of the way it is organized, this book meets the needs of both novice and experienced advance practice nurses. Each chapter defines the problem, how often it occurs, and what leads to the problem. To aid in assessment, the book includes the physical examination landmarks as well as diagnostic tests that might be needed. A plan of care is offered with several different alternatives for treatment and then notes what type of follow-up is needed. This would be a great resource for anyone working in the field of geriatrics...Score: 92 - 4 Stars! --Doody's Reviews This hands-on text and clinical reference--used by thousands of NP students and practitioners alike--delivers national practice guidelines and professional standards of care to help clinicians deliver optimal primary care to adult and older adult patients. The new third edition, featuring the expert input of two renowned Adult-Gerontology practitioners, updates all chapters, teaching guides, and illustrative charts and provides new charts to enhance readability. Fresh content includes information on Sjogren's syndrome; reactive arthritis; elder abuse; LGBTQ health; concussion assessment; joint pain, bursitis, and fractures; peripheral neuropathy; and perimenopause/menopause. The third edition also includes the updated Beers Criteria and covers COVID-19 treatment and vaccines. Ideal for quick reference and as a study guide, the text presents the most up-to-date guidelines in a consistent, easy-to-read, bulleted format. Conveniently organized by body system, it features detailed content on the physical examination and diagnostic testing, information on health promotion, guidelines of care, dietary information, common procedures, national patient resources, and popular Client Teaching Guides--available in print and digital format--that serve as both patient handouts and concise study tools. Clinical points throughout the text highlight critical practice considerations. The book, with its great breadth and depth of information, will be a welcome companion for NP students as they transition to professional practice and beyond. New to the Third Edition: Completely updated content including patient teaching guides and charts New charts added to enhance comprehension Coverage of Sjogren's syndrome; reactive arthritis; elder abuse; LGBTQ health; concussion assessment; joint pain, bursitis, and fractures; peripheral neuropathy, and perimenopause/menopause Latest guidelines on COVID-19 treatment and vaccines Updated Beers Criteria Current CDC recommendations on vaccines and cancer screening Key Features: Offers consistent guidelines for over 275 disorders Presents practice guidelines organized by body system Lists disorders alphabetically for easy access Highlights key considerations for practice Delivers individual care considerations for adult, geriatric, and pregnant patients Provides Client Teaching Guides serving as both take-home teaching supplements for patients and a concise study tool for students

WHO consolidated guidelines on drug-resistant tuberculosis treatment

WHO consolidated guidelines on drug-resistant tuberculosis treatment
Author: World Health Organization
Publisher: World Health Organization
Total Pages: 0
Release: 2018-11-07
Genre: Medical
ISBN: 9789241550529

Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult to treat than drug-susceptible ones, and threaten global progress towards the targets set by the End TB Strategy of the World Health Organization (WHO). There is thus a critical need for evidence-based policy recommendations on the treatment and care of patients with DR-TB, based on the most recent and comprehensive evidence available. In this regard, the WHO consolidated guidelines on drug-resistant tuberculosis treatment fulfil the mandate of WHO to inform health professionals in Member States on how to improve treatment and care for patients with DR-TB. Between 2011 and 2018, WHO has developed and issued evidence-based policy recommendations on the treatment and care of patients with DR-TB. These policy recommendations have been presented in several WHO documents and their associated annexes, including the WHO treatment guidelines for multidrug- and rifampicin-resistant tuberculosis, 2018 update, issued by WHO in December 2018. The policy recommendations in each of these guidelines have been developed by WHO-convened Guideline Development Groups (GDGs), using the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach to summarize the evidence, and formulate policy recommendations and accompanying remarks. The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, including longer and shorter regimens, culture monitoring of patients on treatment, the timing of antiretroviral therapy (ART) in MDR/RR-TB patients infected with the human immunodeficiency virus (HIV), use of surgery for patients receiving MDR-TB treatment, and optimal models of patient support and care.